Abstract:Background: Peripheral artery disease (PAD), which is caused by atherosclerosis, results in progressive narrowing and occlusion of the peripheral arteries and inhibits blood flow to the lower extremities. Therapeutic angiogenesis is a promising strategy for treating ischemia caused by PAD. Nitric oxide (NO) has been shown to be a key mediator of angiogenesis. It has been demonstrated that β-cyclodextrincan stimulate vessel growth in rabbit corneas. In this study, we assessed the mechanism of action and therapeutic potential of a new angiogenic molecule, (2-hydroxypropyl)-β-cyclodextrin (2HP-β-CD). Methods and results: 2HP-β-CD significantly increased vascular endothelial growth factor A (VEGF-A) and platelet-derived growth factor BB (PDGF-BB) peptides in human umbilical vein endothelial cells (HUVECs) and also increased basic fibroblast growth factor (bFGF) peptide in human aortic smooth muscle cells (HASMCs). 2HP-β-CD stimulated both proliferation and migration of HUVECs in an endothelial nitric oxide synthase (eNOS)/NO-dependent manner, whereas NO was found to be involved in proliferation, but not migration, of HASMCs. In a unilateral hindlimb ischemia model in mice, 2HP-β-CD injections not only promoted blood flow recovery and increased microvessel densities in ischemic muscle, but also promoted coverage of the vessels with smooth muscle cells, thus stabilizing the vessels. Administration of 2HP-β-CD increased the expression of several angiogenic factors, including VEGF-A, PDGF-BB and transforming growth factor beta-1 (TGF-β1) in ischemic muscle. Injections of 2HP-β-CD also stimulated protein kinase B and extracellular regulated protein kinases (ERK), leading to an increase in phosphorylation of eNOS in ischemic muscle. Treatment with the NOS inhibitor, Nω-nitro-L-arginine methyl ester (L-NAME), showed that stimulation of blood flow induced by 2HP-β-CD was partially dependent on NO. Conclusions: Therapeutic angiogenesis by 2HP-β-CD may be beneficial to patients with PAD.

A Naturally Derived, Growth Factor-Binding Polysaccharide for Therapeutic Angiogenesis.

Enzymatically cross-linkable sulfated bacterial polyglucuronic acid as an affinity-based carrier of FGF-2 for therapeutic angiogenesis

In Vitro Evaluation of Panax Notoginseng Rg1 Released from Collagen/chitosan-Gelatin Microsphere Scaffolds for Angiogenesis

A Macrophage-Activating, Injectable Hydrogel to Sequester Endogenous Growth Factors for in Situ Angiogenesis.

Structural characterization and pro-angiogenic property of a polysaccharide isolated from red seaweed Bangia fusco-purpurea

Purification, structural elucidation, and in vitro antitumor effects of novel polysaccharides from Bangia fuscopurpurea

Glypican-1 nanoliposomes for potentiating growth factor activity in therapeutic angiogenesis

A “bridge‐building” Glycan Scaffold Mimicking Microbial Invasion for in Situ Endothelialization

A Novel Heterogalactan from Antrodia Camphorata and Anti-Angiogenic Activity of Its Sulfated Derivative

Engineering a Microcarrier Based on a Polysaccharide-Growth Factor Complex for Enhancing the Proliferation of Mesenchymal Stem Cells.

Pro-vasculogenic Fibers by PDA-Mediated Surface Functionalization Using Cell-Free Fat Extract (CEFFE)

In Situ Sequestration of Endogenous PDGF-BB with an ECM-mimetic Sponge for Accelerated Wound Healing

Modular mucopolysaccharide gelatin naturapolyceutics hydrocolloid biomatrix with cobalt nano-additives for high density vascular network assembly

Post-screening Characterisation and in Vivo Evaluation of an Anti-Inflammatory Polysaccharide Fraction from Eucommia Ulmoides.

A natural compound (ginsenoside Re) isolated from Panax ginseng as a novel angiogenic agent for tissue regeneration

Pharmacokinetics, Biodistribution and Receptor Mediated Endocytosis of a Natural Angelica Sinensis Polysaccharide

Controlled Release of Growth Factor from Heparin Embedded Poly(aldehyde guluronate) Hydrogels and Its Effect on Vascularization

Functional structural domain synthesis of anti-pancreatic carcinoma pectin-like polysaccharide RN1

(2-Hydroxypropyl)-β-Cyclodextrin Is a New Angiogenic Molecule for Therapeutic Angiogenesis

Designer Functionalized Self-Assembling Peptide Nanofiber Scaffolds for Growth, Migration, and Tubulogenesis of Human Umbilical Vein Endothelial Cells

A Polysaccharide Isolated from the Medicinal Herb Bletilla striata Induces Endothelial Cells Proliferation and Vascular Endothelial Growth Factor Expression in vitro